{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:58:36Z","timestamp":1790647116274,"version":"4.1.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Bone and soft tissue sarcomas are rare, heterogeneous malignancies presenting major diagnostic and therapeutic challenges. Over the past century, Japanese orthopaedic surgeons have occupied a unique position as both primary surgeons and comprehensive oncologists. On the occasion of the Centennial of the Japanese Orthopaedic Association (JOA), this review synthesizes the key historical milestones and future prospects of Japanese orthopaedic oncology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A narrative synthesis was structured across five consolidated domains: (1) Surgical Innovation; (2) Advanced Basic Research and Novel Therapeutics; (3) The Japan Bone and Soft Tissue Tumor Registry (JBSTTR); (4) Nationwide Collaborative Research Groups and Multidisciplinary Platforms; and (5) Onco-Orthopaedics and Future Musculoskeletal Care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Japanese orthopaedic oncologists established quantitative surgical margin concepts, pioneered Total En Bloc Spondylectomy (TES) for spinal tumours, and developed recycled treated autografts (freezing, pasteurization, and irradiation). Translational research milestones encompass caffeine-potentiated chemotherapy, peptide-based immunotherapy, oncolytic viral therapies, Japan\u2019s first investigator-initiated clinical trial in oncology, and carbon-ion radiotherapy. Furthermore, a robust nationwide infrastructure has been forged through six decades of the JBSTTR alongside collaborative research engines\u2014the Japanese Musculoskeletal Oncology Group (JMOG), the Japan Clinical Oncology Group Bone and Soft Tissue Tumor Study Group (JCOG-BSTTSG), and the Japan Ewing Sarcoma Study Group (JESS)\u2014and the multidisciplinary platform Japanese Association of Sarcoma Treatment and Research (JSTAR). Expanding beyond primary sarcoma care, the conceptual framework of Onco-Orthopaedics has pioneered a holistic paradigm for managing locomotive syndrome in cancer patients \"Cancer Locomo\".<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The surgeon-led collaborative ecosystem in Japan bridges surgical precision, translational science, and nationwide multidisciplinary platforms, offering a sustainable model for advancing musculoskeletal oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00264-026-06999-6","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:40:52Z","timestamp":1788327652000},"page":"2729-2741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Historical contributions and future horizons of Japanese orthopaedic oncology: from surgical innovation to nationwide collaborations"],"prefix":"10.1007","volume":"50","author":[{"given":"Akira","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7063-9609","authenticated-orcid":false,"given":"Keisuke","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"6999_CR1","volume-title":"WHO classification of tumours, 5th edition, volume 3: Soft tissue and bone tumours","author":"World Health Organization","year":"2020","unstructured":"World Health Organization (2020) WHO classification of tumours, 5th edition, volume 3: Soft tissue and bone tumours. IARC Press, Lyon"},{"key":"6999_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00003086-198011000-00013","volume":"153","author":"WF Enneking","year":"1980","unstructured":"Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106\u2013120","journal-title":"Clin Orthop Relat Res"},{"key":"6999_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00003086-200402000-00027","volume":"419","author":"N Kawaguchi","year":"2004","unstructured":"Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y (2004) The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 419:165\u2013172","journal-title":"Clin Orthop Relat Res"},{"key":"6999_CR4","volume-title":"Evaluation system for surgical margins in bone and soft tissue tumors","author":"Japanese Orthopaedic Association","year":"1989","unstructured":"Japanese Orthopaedic Association (1989) Evaluation system for surgical margins in bone and soft tissue tumors. Kanehara & Co., Ltd., Tokyo"},{"issue":"3","key":"6999_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00007632-199702010-00018","volume":"22","author":"K Tomita","year":"1976","unstructured":"Tomita K, Kawahara N, Baba H, Tsuchiya H, Fujita T, Toribatake Y (1976) Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors. Spine (Phila Pa 1976) 22(3):324\u2013333","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"6999_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF00180229","volume":"18","author":"K Tomita","year":"1994","unstructured":"Tomita K, Kawahara N, Baba H, Tsuchiya H, Nagata S, Toribatake Y (1994) Total en bloc spondylectomy for solitary spinal metastases. Int Orthop. 18(5):291\u2013298","journal-title":"Int Orthop."},{"issue":"3","key":"6999_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/00007632-200102010-00016","volume":"26","author":"K Tomita","year":"1976","unstructured":"Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (1976) Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 26(3):298\u2013306","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"6999_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ocl.2008.09.004","volume":"40","author":"N Kawahara","year":"2009","unstructured":"Kawahara N, Tomita K, Murakami H, Demura S (2009) Total en bloc spondylectomy for spinal tumors: surgical techniques and related basic background. Orthop Clin North Am 40(1):47\u201363","journal-title":"Orthop Clin North Am"},{"issue":"11","key":"6999_CR9","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1302\/0301-620X.96B11.34747","volume":"96-B","author":"ER Henderson","year":"2014","unstructured":"Henderson ER, O\u2019Connor MI, Ruggieri P et al (2014) Classification of failure of limb salvage after reconstructive surgery for bone tumours: a modified system including biological and expandable reconstructions. Bone Joint J 96-B(11):1436\u20131440","journal-title":"Bone Joint J"},{"issue":"3","key":"6999_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jos.2019.01.015","volume":"24","author":"N Yamamoto","year":"2019","unstructured":"Yamamoto N, Hayashi K, Tsuchiya H (2019) Progress in biological reconstruction and enhanced bone revitalization for bone defects. J Orthop Sci. 24(3):387\u2013392","journal-title":"J Orthop Sci."},{"issue":"2","key":"6999_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1302\/0301-620X.87B2.15325","volume":"87","author":"H Tsuchiya","year":"2005","unstructured":"Tsuchiya H, Wan SL, Sakayama K, Yamamoto N, Nishida H, Tomita K (2005) Reconstruction using an autograft containing tumour treated by liquid nitrogen. J Bone Joint Surg Br. 87(2):218\u2013225","journal-title":"J Bone Joint Surg Br."},{"issue":"4","key":"6999_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1302\/0301-620X.96B4.32629","volume":"96-B","author":"K Igarashi","year":"2014","unstructured":"Igarashi K, Yamamoto N, Shirai T et al (2014) The long-term outcome following the use of frozen autograft treated with liquid nitrogen in the management of bone and soft-tissue sarcomas. Bone Joint J 96-B(4):555\u2013561","journal-title":"Bone Joint J"},{"issue":"3","key":"6999_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00776-010-1458-0","volume":"15","author":"H Tsuchiya","year":"2010","unstructured":"Tsuchiya H, Nishida H, Srisawat P et al (2010) Pedicle frozen autograft reconstruction in malignant bone tumors. J Orthop Sci. 15(3):340\u2013349","journal-title":"J Orthop Sci."},{"key":"6999_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00003086-200402000-00042","volume":"419","author":"J Manabe","year":"2004","unstructured":"Manabe J, Ahmed AR, Kawaguchi N, Matsumoto S, Kuroda H (2004) Pasteurized autologous bone graft in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 419:258\u2013266","journal-title":"Clin Orthop Relat Res"},{"key":"6999_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/BLO.0b013e31802e7ec8","volume":"456","author":"DG Jeon","year":"2007","unstructured":"Jeon DG, Kim MS, Cho WH, Song WS, Lee SY (2007) Pasteurized autograft for intercalary reconstruction: an alternative to allograft. Clin Orthop Relat Res. 456:203\u2013210","journal-title":"Clin Orthop Relat Res."},{"key":"6999_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/00003086-199911000-00024","volume":"368","author":"N Araki","year":"1999","unstructured":"Araki N, Myoui A, Kuratsu S et al (1999) Intraoperative extracorporeal autogenous irradiated bone grafts in tumor surgery. Clin Orthop Relat Res. 368:196\u2013206","journal-title":"Clin Orthop Relat Res."},{"issue":"7","key":"6999_CR17","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/jso.27629","volume":"129","author":"Y Takeuchi","year":"2024","unstructured":"Takeuchi Y, Sakamoto A, Noguchi T, Toguchida J, Matsuda S (2024) Recycled bone grafts treated with extracorporeal irradiation or liquid nitrogen freezing after malignant tumor resection. J Surg Oncol. 129(7):1364\u20131373","journal-title":"J Surg Oncol."},{"issue":"11","key":"6999_CR18","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1097\/CORR.0000000000002720","volume":"481","author":"A Takeuchi","year":"2023","unstructured":"Takeuchi A, Tsuchiya H, Setsu N et al (2023) What are the complications, function, and survival of tumor-devitalized autografts used in patients with limb-sparing surgery for bone and soft tissue tumors? A Japanese musculoskeletal oncology group multi-institutional study. Clin Orthop Relat Res. 481(11):2110\u20132124","journal-title":"Clin Orthop Relat Res."},{"key":"6999_CR19","doi-asserted-by":"publisher","first-page":"861575","DOI":"10.1155\/2015\/861575","volume":"2015","author":"K Ogura","year":"2015","unstructured":"Ogura K, Miyamoto S, Sakuraba M, Fujiwara T, Chuman H, Kawai A (2015) Intercalary reconstruction after wide resection of malignant bone tumors of the lower extremity using a composite graft with a devitalized autograft and a vascularized fibula. Sarcoma. 2015:861575","journal-title":"Sarcoma."},{"key":"6999_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00003086-199605000-00029","volume":"326","author":"A Uchida","year":"1996","unstructured":"Uchida A, Myoui A, Araki N, Yoshikawa H, Ueda T, Aoki Y (1996) Prosthetic reconstruction for periacetabular malignant tumors. Clin Orthop Relat Res. 326:238\u2013245","journal-title":"Clin Orthop Relat Res."},{"issue":"5","key":"6999_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00776-012-0247-3","volume":"17","author":"H Tsuchiya","year":"2012","unstructured":"Tsuchiya H, Shirai T, Nishida H et al (2012) Innovative antimicrobial coating of titanium implants with iodine. J Orthop Sci. 17(5):595\u2013604","journal-title":"J Orthop Sci."},{"issue":"4","key":"6999_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/0885328214539365","volume":"29","author":"T Shirai","year":"2014","unstructured":"Shirai T, Tsuchiya H, Nishida H et al (2014) Antimicrobial megaprostheses supported with iodine. J Biomater Appl. 29(4):617\u2013623","journal-title":"J Biomater Appl."},{"issue":"3","key":"6999_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jos.2018.10.010","volume":"24","author":"D Inoue","year":"2019","unstructured":"Inoue D, Kabata T, Kajino Y, Shirai T, Tsuchiya H (2019) Iodine-supported titanium implants have good antimicrobial attachment effects. J Orthop Sci. 24(3):548\u2013551","journal-title":"J Orthop Sci."},{"issue":"14","key":"6999_CR24","first-page":"3939","volume":"48","author":"J Toguchida","year":"1988","unstructured":"Toguchida J, Ishizaki K, Sasaki MS et al (1988) Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res. 48(14):3939\u20133943","journal-title":"Cancer Res."},{"issue":"6211","key":"6999_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/338156a0","volume":"338","author":"J Toguchida","year":"1989","unstructured":"Toguchida J, Ishizaki K, Sasaki MS et al (1989) Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature. 338(6211):156\u2013158","journal-title":"Nature."},{"issue":"9","key":"6999_CR26","first-page":"2419","volume":"52","author":"T Yamaguchi","year":"1992","unstructured":"Yamaguchi T, Toguchida J, Yamamuro T et al (1992) Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res. 52(9):2419\u20132423","journal-title":"Cancer Res."},{"issue":"20","key":"6999_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM199205143262001","volume":"326","author":"J Toguchida","year":"1992","unstructured":"Toguchida J, Yamaguchi T, Dayton SH et al (1992) Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med. 326(20):1301\u20131308","journal-title":"N Engl J Med."},{"issue":"22","key":"6999_CR28","first-page":"6194","volume":"52","author":"J Toguchida","year":"1992","unstructured":"Toguchida J, Yamaguchi T, Ritchie B et al (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 52(22):6194\u20136199","journal-title":"Cancer Res."},{"issue":"3","key":"6999_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1056\/NEJM199801153380303","volume":"338","author":"A Kawai","year":"1998","unstructured":"Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M (1998) SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 338(3):153\u2013160","journal-title":"N Engl J Med."},{"issue":"1","key":"6999_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00019606-200003000-00001","volume":"9","author":"CR Antonescu","year":"2000","unstructured":"Antonescu CR, Kawai A, Leung DH et al (2000) Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol. 9(1):1\u20138","journal-title":"Diagn Mol Pathol."},{"issue":"2","key":"6999_CR31","first-page":"467","volume":"19","author":"S Takenaka","year":"2008","unstructured":"Takenaka S, Ueda T, Naka N et al (2008) Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan. Oncol Rep. 19(2):467\u2013476","journal-title":"Oncol Rep."},{"issue":"9","key":"6999_CR32","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s11999-008-0330-4","volume":"466","author":"A Kawai","year":"2008","unstructured":"Kawai A, Kondo T, Suehara Y, Kikuta K, Hirohashi S (2008) Global protein-expression analysis of bone and soft tissue sarcomas. Clin Orthop Relat Res. 466(9):2099\u20132106","journal-title":"Clin Orthop Relat Res."},{"issue":"1","key":"6999_CR33","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1038\/s41467-018-03891-9","volume":"9","author":"K Ogura","year":"2018","unstructured":"Ogura K, Hosoda F, Arai Y et al (2018) Integrated genetic and epigenetic analysis of myxofibrosarcoma. Nat Commun. 9(1):2765","journal-title":"Nat Commun."},{"issue":"1","key":"6999_CR34","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1038\/s41467-019-13286-z","volume":"10","author":"M Hirata","year":"2019","unstructured":"Hirata M, Asano N, Katayama K et al (2019) Integrated exome and RNA sequencing of dedifferentiated liposarcoma. Nat Commun. 10(1):5683","journal-title":"Nat Commun."},{"issue":"5B","key":"6999_CR35","first-page":"3651","volume":"18","author":"H Tsuchiya","year":"1998","unstructured":"Tsuchiya H, Tomita K, Yamamoto N, Mori Y, Asada N (1998) Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Anticancer Res. 18(5B):3651\u20133656","journal-title":"Anticancer Res."},{"issue":"5","key":"6999_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00776-009-1372-5","volume":"14","author":"H Kimura","year":"2009","unstructured":"Kimura H, Tsuchiya H, Shirai T et al (2009) Caffeine-potentiated chemotherapy for metastatic osteosarcoma. J Orthop Sci. 14(5):556\u2013565","journal-title":"J Orthop Sci."},{"issue":"1","key":"6999_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12885-019-5891-y","volume":"19","author":"K Abe","year":"2019","unstructured":"Abe K, Yamamoto N, Hayashi K, Takeuchi A, Tsuchiya H (2019) Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo. BMC Cancer 19(1):689","journal-title":"BMC Cancer"},{"issue":"1","key":"6999_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00264-006-0289-2","volume":"32","author":"K Hayashi","year":"2008","unstructured":"Hayashi K, Tsuchiya H, Yamamoto N, Takeuchi A, Tomita K (2008) Functional outcome in patients with osteosarcoma around the knee joint treated by minimised surgery. Int Orthop 32(1):63\u201368","journal-title":"Int Orthop"},{"issue":"5B","key":"6999_CR39","first-page":"3489","volume":"27","author":"A Takeuchi","year":"2007","unstructured":"Takeuchi A, Tsuchiya H, Yamamoto N et al (2007) Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome. Anticancer Res. 27(5B):3489\u20133495","journal-title":"Anticancer Res."},{"issue":"3","key":"6999_CR40","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.4049\/jimmunol.169.3.1611","volume":"169","author":"Y Sato","year":"2002","unstructured":"Sato Y, Nabeta Y, Tsukahara T et al (2002) Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma. J Immunol. 169(3):1611\u20131618","journal-title":"J Immunol."},{"issue":"15","key":"6999_CR41","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1158\/0008-5472.CAN-04-0522","volume":"64","author":"T Tsukahara","year":"2004","unstructured":"Tsukahara T, Nabeta Y, Kawaguchi S et al (2004) Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor. Cancer Res. 64(15):5442\u20135448","journal-title":"Cancer Res."},{"issue":"1","key":"6999_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-3-1","volume":"3","author":"S Kawaguchi","year":"2005","unstructured":"Kawaguchi S, Wada T, Ida K et al (2005) Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma. J Transl Med. 3(1):1","journal-title":"J Transl Med."},{"issue":"9","key":"6999_CR43","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/j.1349-7006.2012.02370.x","volume":"103","author":"S Kawaguchi","year":"2012","unstructured":"Kawaguchi S, Tsukahara T, Ida K et al (2012) SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese musculoskeletal oncology group. Cancer Sci. 103(9):1625\u20131630","journal-title":"Cancer Sci."},{"issue":"12","key":"6999_CR44","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1158\/0008-5472.CAN-04-2657","volume":"65","author":"J Kamizono","year":"2005","unstructured":"Kamizono J, Nagano S, Murofushi Y et al (2005) Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication. Cancer Res 65(12):5284\u20135291","journal-title":"Cancer Res"},{"issue":"10","key":"6999_CR45","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/cgt.2011.44","volume":"18","author":"Y Horikawa","year":"2011","unstructured":"Horikawa Y, Wang Y, Nagano S et al (2011) Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses: implications for the generation of ideal m-CRAs. Cancer Gene Ther 18(10):724\u2013733","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"6999_CR46","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s00776-010-1506-9","volume":"15","author":"H Sugiura","year":"2010","unstructured":"Sugiura H, Fujiwara Y, Ando M et al (2010) Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma. J Orthop Sci. 15(5):654\u2013660","journal-title":"J Orthop Sci."},{"issue":"3","key":"6999_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/jjco\/hyv184","volume":"46","author":"A Kawai","year":"2016","unstructured":"Kawai A, Araki N, Hiraga H et al (2016) A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup. Jpn J Clin Oncol. 46(3):248\u2013253","journal-title":"Jpn J Clin Oncol."},{"issue":"1","key":"6999_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ijc.33201","volume":"148","author":"Y Nishida","year":"2021","unstructured":"Nishida Y, Urakawa H, Nakayama R et al (2021) Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors. Int J Cancer. 148(1):140\u2013149","journal-title":"Int J Cancer."},{"issue":"4","key":"6999_CR49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10637-014-0094-5","volume":"32","author":"T Ueda","year":"2014","unstructured":"Ueda T, Kakunaga S, Ando M et al (2014) Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma. Invest New Drugs. 32(4):691\u2013699","journal-title":"Invest New Drugs."},{"issue":"4","key":"6999_CR50","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1470-2045(15)70098-7","volume":"16","author":"A Kawai","year":"2015","unstructured":"Kawai A, Araki N, Sugiura H et al (2015) Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Lancet Oncol. 16(4):406\u2013416","journal-title":"Lancet Oncol."},{"key":"6999_CR51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejca.2015.12.014","volume":"56","author":"N Araki","year":"2016","unstructured":"Araki N, Takahashi S, Sugiura H et al (2016) Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy. Eur J Cancer. 56:122\u2013130","journal-title":"Eur J Cancer."},{"key":"6999_CR52","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12885-016-2511-y","volume":"16","author":"H Morioka","year":"2016","unstructured":"Morioka H, Takahashi S, Araki N et al (2016) Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma. BMC Cancer. 16:479","journal-title":"BMC Cancer."},{"issue":"11","key":"6999_CR53","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1002\/cam4.2991","volume":"9","author":"M Endo","year":"2020","unstructured":"Endo M, Takahashi S, Araki N et al (2020) Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials. Cancer Med. 9(11):3656\u20133667","journal-title":"Cancer Med."},{"issue":"2","key":"6999_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jjco\/hyw175","volume":"47","author":"A Kawai","year":"2017","unstructured":"Kawai A, Araki N, Naito Y et al (2017) Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma. Jpn J Clin Oncol. 47(2):137\u2013144","journal-title":"Jpn J Clin Oncol."},{"issue":"1","key":"6999_CR55","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12885-022-09527-y","volume":"22","author":"A Kawai","year":"2022","unstructured":"Kawai A, Narahara H, Takahashi S et al (2022) Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: a post-marketing observational study. BMC Cancer. 22(1):528","journal-title":"BMC Cancer."},{"issue":"9","key":"6999_CR56","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/cncr.29961","volume":"122","author":"T Nakamura","year":"2016","unstructured":"Nakamura T, Matsumine A, Kawai A et al (2016) The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study. Cancer. 122(9):1408\u20131416","journal-title":"Cancer."},{"issue":"7","key":"6999_CR57","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s12325-017-0561-4","volume":"34","author":"A Kawai","year":"2017","unstructured":"Kawai A, Yonemori K, Takahashi S, Araki N, Ueda T (2017) Systemic therapy for soft tissue sarcoma: proposals for the optimal use of pazopanib, trabectedin, and eribulin. Adv Ther. 34(7):1556\u20131571","journal-title":"Adv Ther."},{"issue":"12","key":"6999_CR58","first-page":"6959","volume":"37","author":"R Imai","year":"2017","unstructured":"Imai R, Kamada T, Araki N, Working Group for Bone and Soft-Tissue Sarcomas (2017) Clinical efficacy of carbon ion radiotherapy for unresectable chondrosarcomas. Anticancer Res. 37(12):6959\u20136964","journal-title":"Anticancer Res."},{"issue":"9","key":"6999_CR59","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1002\/cam4.1679","volume":"7","author":"R Imai","year":"2018","unstructured":"Imai R, Kamada T, Araki N, Working Group for Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas (2018) Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma. Cancer Med 7(9):4308\u20134314","journal-title":"Cancer Med"},{"issue":"33","key":"6999_CR60","doi-asserted-by":"publisher","first-page":"22976","DOI":"10.18632\/oncotarget.25165","volume":"9","author":"O Mohamad","year":"2018","unstructured":"Mohamad O, Imai R, Kamada T, Nitta Y, Araki N, Working Group for Bone and Soft Tissue Sarcoma (2018) Carbon ion radiotherapy for inoperable pediatric osteosarcoma. Oncotarget 9(33):22976\u201322985","journal-title":"Oncotarget"},{"issue":"17","key":"6999_CR61","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1158\/1078-0432.CCR-04-0301","volume":"10","author":"R Imai","year":"2004","unstructured":"Imai R, Kamada T, Tsuji H et al (2004) Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res. 10(17):5741\u20135746","journal-title":"Clin Cancer Res."},{"issue":"19","key":"6999_CR62","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1002\/cncr.28177","volume":"119","author":"K Matsumoto","year":"2013","unstructured":"Matsumoto K, Imai R, Kamada T et al (2013) Impact of carbon ion radiotherapy for primary spinal sarcoma. Cancer. 119(19):3496\u20133503","journal-title":"Cancer."},{"key":"6999_CR63","volume-title":"Bone tumor registry in Japan","author":"JOA Musculoskeletal Tumor Committee","year":"2022","unstructured":"JOA Musculoskeletal Tumor Committee (2022) Bone tumor registry in Japan. Japanese Orthopaedic Association, Tokyo"},{"key":"6999_CR64","volume-title":"Soft tissue tumor registry in Japan","author":"JOA Musculoskeletal Tumor Committee","year":"2022","unstructured":"JOA Musculoskeletal Tumor Committee (2022) Soft tissue tumor registry in Japan. Japanese Orthopaedic Association, Tokyo"},{"issue":"Suppl 5","key":"6999_CR65","first-page":"35","volume":"78","author":"A Kawai","year":"2020","unstructured":"Kawai A (2020) National bone and soft tissue tumor registry in Japan. Nihon Rinsho. 78(Suppl 5):35\u201342","journal-title":"Nihon Rinsho."},{"issue":"3","key":"6999_CR66","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jos.2022.02.003","volume":"27","author":"A Kawai","year":"2022","unstructured":"Kawai A (2022) The shape of tumor treatment in this Country. J Orthop Sci. 27(3):511\u2013513","journal-title":"J Orthop Sci."},{"issue":"1","key":"6999_CR67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jos.2016.10.006","volume":"22","author":"K Ogura","year":"2017","unstructured":"Ogura K, Higashi T, Kawai A (2017) Statistics of bone sarcoma in Japan: report from the bone and soft tissue tumor registry in Japan. J Orthop Sci 22(1):133\u2013143","journal-title":"J Orthop Sci"},{"issue":"4","key":"6999_CR68","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jos.2017.03.017","volume":"22","author":"K Ogura","year":"2017","unstructured":"Ogura K, Higashi T, Kawai A (2017) Statistics of soft-tissue sarcoma in Japan: report from the bone and soft tissue tumor registry in Japan. J Orthop Sci. 22(4):755\u2013764","journal-title":"J Orthop Sci."},{"issue":"9","key":"6999_CR69","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/jjco\/hyaf094","volume":"55","author":"K Ogura","year":"2025","unstructured":"Ogura K, Kawano H, Shimose S, Hiraoka K, Matsumine A, Kawai A (2025) Osteosarcoma in Japan: report from the bone and soft tissue tumor registry 2006\u20132022. Jpn J Clin Oncol. 55(9):1046\u20131053","journal-title":"Jpn J Clin Oncol."},{"issue":"11","key":"6999_CR70","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1007\/s10147-019-01512-z","volume":"24","author":"Y Nishida","year":"2019","unstructured":"Nishida Y, Kawai A, Toguchida J et al (2019) Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan. Int J Clin Oncol. 24(11):1498\u20131505","journal-title":"Int J Clin Oncol."},{"issue":"1","key":"6999_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4487-2","volume":"18","author":"Y Tsuda","year":"2018","unstructured":"Tsuda Y, Ogura K, Shinoda Y, Kobayashi H, Tanaka S, Kawai A (2018) The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences. BMC Cancer 18(1):614","journal-title":"BMC Cancer"},{"issue":"13","key":"6999_CR72","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.3390\/cancers13133320","volume":"13","author":"S Takenaka","year":"2021","unstructured":"Takenaka S, Tamiya H, Wakamatsu T et al (2021) Impact of surgical resection and reasons for poor prognosis of pelvic osteosarcoma based on the bone tumor registry in Japan. Cancers (Basel). 13(13):3320","journal-title":"Cancers (Basel)."},{"issue":"1","key":"6999_CR73","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1186\/s12885-022-09968-5","volume":"22","author":"T Fujiwara","year":"2022","unstructured":"Fujiwara T, Nakata E, Kunisada T, Ozaki T, Kawai A (2022) Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study. BMC Cancer. 22(1):891","journal-title":"BMC Cancer."},{"issue":"11","key":"6999_CR74","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1302\/0301-620X.105B11.BJJ-2022-0743.R3","volume":"105-B","author":"T Fujiwara","year":"2023","unstructured":"Fujiwara T, Kunisada T, Nakata E, Mitsuhashi T, Ozaki T, Kawai A (2023) Factors associated with survival in patients with clear cell sarcoma. Bone Joint J 105-B(11):1216\u20131225","journal-title":"Bone Joint J"},{"issue":"5","key":"6999_CR75","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1245\/s10434-022-12868-4","volume":"30","author":"S Kamio","year":"2023","unstructured":"Kamio S, Matsumoto M, Nakamura M, Kawai A, Kikuta K (2023) Epidemiologic survey of myxofibrosarcoma using data from the bone and soft tissue tumor registry in Japan. Ann Surg Oncol. 30(5):3074\u20133081","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"6999_CR76","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/jjco\/hyae053","volume":"54","author":"H Kobayashi","year":"2024","unstructured":"Kobayashi H, Okajima K, Zhang L et al (2024) Embryonal and alveolar rhabdomyosarcoma in adolescents\/young adults, adults and older adults: a population-based cohort study. Jpn J Clin Oncol 54(8):903\u2013910","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"6999_CR77","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jos.2023.06.008","volume":"29","author":"T Morii","year":"2024","unstructured":"Morii T, Ogura K, Sato K, Kawai A (2024) Incidence and risk of surgical site infection\/periprosthetic joint infection in tumor endoprosthesis-data from the nationwide bone tumor registry in Japan. J Orthop Sci. 29(4):1112\u20131118","journal-title":"J Orthop Sci."},{"issue":"8","key":"6999_CR78","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/curroncol32080454","volume":"32","author":"T Morii","year":"2025","unstructured":"Morii T, Sato K, Ogura K, Shinozaki T, Kawai A (2025) Impact of postoperative infection on lower limb function after surgery for malignant bone and soft tissue tumors: data from a nationwide registry in Japan. Curr Oncol. 32(8):454","journal-title":"Curr Oncol."},{"issue":"7","key":"6999_CR79","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/jso.70236","volume":"133","author":"S Kamio","year":"2026","unstructured":"Kamio S, Ogura K, Sato K et al (2026) Analysis of the relationship between survival and postoperative infection in patients with osteosarcoma. J Surg Oncol. 133(7):959\u2013965","journal-title":"J Surg Oncol."},{"issue":"11","key":"6999_CR80","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1302\/0301-620X.107B11.BJJ-2025-0067.R1","volume":"107-B","author":"H Kobayashi","year":"2025","unstructured":"Kobayashi H, Okajima K, Ando T et al (2025) Incidence and prognostic impact of regional lymph node metastasis at the time of diagnosis in soft-tissue sarcoma: a population-based cohort study. Bone Joint J. 107-B(11):1229\u20131236","journal-title":"Bone Joint J."},{"key":"6999_CR81","doi-asserted-by":"crossref","unstructured":"Tsuchiya R, Ogura K, Ohtori S, Kawai A (2026) Statistics of primary malignant spine tumors in Japan: a retrospective study using the bone and soft tissue tumor registry in Japan. Spine (Phila Pa 1976) 51(7):496\u2013502","DOI":"10.1097\/BRS.0000000000005361"},{"issue":"4","key":"6999_CR82","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jos.2025.12.015","volume":"31","author":"R Tsuchiya","year":"2026","unstructured":"Tsuchiya R, Ogura K, Ohtori S, Kawai A (2026) Descriptive analysis of primary intermediate and benign spine tumors: a retrospective study using the Bone and Soft Tissue Tumor Registry in Japan. J Orthop Sci 31(4):908\u2013915","journal-title":"J Orthop Sci"},{"issue":"1","key":"6999_CR83","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s12885-019-5875-y","volume":"19","author":"M Sekimizu","year":"2019","unstructured":"Sekimizu M, Ogura K, Yasunaga H et al (2019) Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan. BMC Cancer. 19(1):657","journal-title":"BMC Cancer."},{"key":"6999_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-026-06961-6","author":"J Iwatsu","year":"2026","unstructured":"Iwatsu J, Ogura K, Morii T, Sato K, Kawai A (2026) Association between postoperative surgical site infection and oncologic outcomes in soft tissue sarcoma: a propensity score-matched analysis using the bone and soft tissue registry. Int Orthop. https:\/\/doi.org\/10.1007\/s00264-026-06961-6","journal-title":"Int Orthop"},{"issue":"12","key":"6999_CR85","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1302\/0301-620X.103B12.BJJ-2021-0037.R1","volume":"103-B","author":"T Nakamura","year":"2021","unstructured":"Nakamura T, Kawai A, Hagi T, Asanuma K, Sudo A (2021) A comparison of clinical outcomes between additional excision after unplanned and planned excisions in patients with soft-tissue sarcoma of the limb: a propensity matching cohort study. Bone Joint J 103-B(12):1809\u20131814","journal-title":"Bone Joint J"},{"issue":"4","key":"6999_CR86","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/cncr.22481","volume":"109","author":"H Obata","year":"2007","unstructured":"Obata H, Ueda T, Kawai A et al (2007) Clinical outcome of patients with ewing sarcoma family of tumors of bone in Japan: the Japanese musculoskeletal oncology group cooperative study. Cancer. 109(4):767\u2013775","journal-title":"Cancer."},{"issue":"1","key":"6999_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cncr.22380","volume":"109","author":"A Kawai","year":"2007","unstructured":"Kawai A, Hosono A, Nakayama R et al (2007) Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients. Cancer. 109(1):109\u2013116","journal-title":"Cancer."},{"issue":"11","key":"6999_CR88","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1097\/CORR.0000000000001266","volume":"478","author":"R Nakayama","year":"2020","unstructured":"Nakayama R, Hayakawa K, Kobayashi E et al (2020) What factors are associated with treatment outcomes of Japanese patients with clear cell chondrosarcoma? Clin Orthop Relat Res. 478(11):2537\u20132547","journal-title":"Clin Orthop Relat Res."},{"issue":"7","key":"6999_CR89","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1111\/cas.15382","volume":"113","author":"E Kozawa","year":"2022","unstructured":"Kozawa E, Nishida Y, Kawai A et al (2022) Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study. Cancer Sci. 113(7):2397\u20132408","journal-title":"Cancer Sci."},{"issue":"16","key":"6999_CR90","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1200\/JCO.2002.11.028","volume":"20","author":"H Tsuchiya","year":"2002","unstructured":"Tsuchiya H, Kanazawa Y, Abdel-Wanis ME et al (2002) Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese musculoskeletal oncology group study. J Clin Oncol. 20(16):3470\u20133477","journal-title":"J Clin Oncol."},{"issue":"3","key":"6999_CR91","first-page":"595","volume":"88","author":"H Futani","year":"2006","unstructured":"Futani H, Minamizaki T, Nishimoto Y, Abe S, Yabe H, Ueda T (2006) Long-term follow-up after limb salvage in skeletally immature children with a primary malignant tumor of the distal end of the femur. J Bone Joint Surg Am. 88(3):595\u2013603","journal-title":"J Bone Joint Surg Am."},{"issue":"7","key":"6999_CR92","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/jso.25005","volume":"117","author":"K Ogura","year":"2018","unstructured":"Ogura K, Susa M, Morioka H et al (2018) Reconstruction using a constrained-type hip tumor prosthesis after resection of malignant periacetabular tumors: A study by the Japanese Musculoskeletal Oncology Group (JMOG). J Surg Oncol. 117(7):1455\u20131463","journal-title":"J Surg Oncol."},{"issue":"4","key":"6999_CR93","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/CORR.0000000000002874","volume":"482","author":"T Mori","year":"2024","unstructured":"Mori T, Kobayashi E, Sato Y et al (2024) What are the complication rates and factors associated with total femur replacement after tumor resection? findings from the Japanese musculoskeletal oncology group. Clin Orthop Relat Res. 482(4):702\u2013712","journal-title":"Clin Orthop Relat Res."},{"issue":"8","key":"6999_CR94","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1302\/2633-1462.68.BJO-2025-0062.R1","volume":"6","author":"Y Tsuda","year":"2025","unstructured":"Tsuda Y, Nishida Y, Sakamoto A et al (2025) Long-term functional and quality of life outcomes after cementless minimally invasive extendable endoprosthesis replacement in skeletally immature patients with bone sarcomas at the lower limb: a Japanese Musculoskeletal Oncology Group (JMOG) study. Bone Jt Open. 6(8):954\u2013963","journal-title":"Bone Jt Open."},{"issue":"7","key":"6999_CR95","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1245\/s10434-020-09308-6","volume":"28","author":"S Iwata","year":"2021","unstructured":"Iwata S, Kawai A, Ueda T, Ishii T, Japanese Musculoskeletal Oncology Group (JMOG) (2021) Symptomatic venous thromboembolism in patients with malignant bone and soft tissue tumors: a prospective multicenter cohort study. Ann Surg Oncol 28(7):3919\u20133927","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"6999_CR96","first-page":"555","volume":"45","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Mizusawa J, Fukuda H et al (2015) Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304). Jpn J Clin Oncol. 45(6):555\u2013561","journal-title":"Jpn J Clin Oncol."},{"issue":"1","key":"6999_CR97","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1186\/s12885-019-6114-2","volume":"19","author":"K Tanaka","year":"2019","unstructured":"Tanaka K, Mizusawa J, Naka N et al (2019) Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304. BMC Cancer 19(1):890","journal-title":"BMC Cancer"},{"key":"6999_CR98","doi-asserted-by":"crossref","unstructured":"Tanaka K, Machida R, Kawai A, et al (2022) Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II\/III study JCOG1306. Br J Cancer 127(8):1487\u20131496","DOI":"10.1038\/s41416-022-01912-5"},{"issue":"4","key":"6999_CR99","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00776-009-1347-6","volume":"14","author":"Y Iwamoto","year":"2009","unstructured":"Iwamoto Y, Tanaka K, Isu K et al (2009) Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J. J Orthop Sci. 14(4):397\u2013404","journal-title":"J Orthop Sci."},{"issue":"16","key":"6999_CR100","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1200\/JCO-24-01281","volume":"43","author":"H Hiraga","year":"2025","unstructured":"Hiraga H, Machida R, Kawai A et al (2025) Methotrexate, doxorubicin, and cisplatin versus methotrexate, doxorubicin, and cisplatin + ifosfamide in poor responders to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (JCOG0905): A multicenter, open-label randomized trial. J Clin Oncol. 43(16):1886\u20131897","journal-title":"J Clin Oncol."},{"issue":"1","key":"6999_CR101","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12885-023-10693-w","volume":"23","author":"M Endo","year":"2023","unstructured":"Endo M, Kataoka T, Fujiwara T et al (2023) Protocol for the 2ND-STEP study, Japan clinical oncology group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib. BMC Cancer. 23(1):219","journal-title":"BMC Cancer."},{"key":"6999_CR102","doi-asserted-by":"crossref","unstructured":"Endo M, Fujiwara T, Takahashi M, et al (2025) A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib (2ND-STEP, JCOG1802). J Clin Oncol. 43(16_suppl):Abstract 11550.","DOI":"10.1200\/JCO.2026.44.16_suppl.11508"},{"issue":"3","key":"6999_CR103","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/jjco\/hyae160","volume":"55","author":"Y Funauchi","year":"2025","unstructured":"Funauchi Y, Tsukushi S, Hiraga H et al (2025) Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS). Jpn J Clin Oncol 55(3):297\u2013303","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"6999_CR104","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1245\/s10434-023-13500-9","volume":"30","author":"J Lambdin","year":"2023","unstructured":"Lambdin J, Ryan C, Gregory S, Cardona K, Hernandez JM, van Houdt WJ, Gronchi A (2023) A randomized phase III study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with high-risk retroperitoneal sarcoma (STRASS2). Ann Surg Oncol. 30(8):4573\u20134575","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"6999_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28194","volume":"67","author":"M Chin","year":"2020","unstructured":"Chin M, Yokoyama R, Sumi M et al (2020) Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: results of the Japan Ewing Sarcoma Study 04. Pediatr Blood Cancer 67(5):e28194","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"6999_CR106","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2106\/00004623-197961040-00034","volume":"61","author":"HJ Mankin","year":"1979","unstructured":"Mankin HJ, Henry L, Jaffe MD (1979) 1896\u20131979. J Bone Joint Surg Am. 61(4):632\u2013633","journal-title":"J Bone Joint Surg Am."},{"key":"6999_CR107","unstructured":"Japanese Association of Sarcoma Treatment and Research. JSTAR official website. Available from: https:\/\/jstar.or.jp\/. Accessed Aug 2026."},{"key":"6999_CR108","unstructured":"Japanese Association of Sarcoma Treatment and Research (ed) (2021) Clinical practice guidelines for retroperitoneal sarcoma 2021. Igaku Tosho Shuppan, Tokyo"},{"issue":"4","key":"6999_CR109","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10147-023-02312-2","volume":"28","author":"M Hirahata","year":"2023","unstructured":"Hirahata M, Imanishi J, Fujinuma W et al (2023) Cancer may accelerate locomotive syndrome and deteriorate quality of life: a single-centre cross-sectional study of locomotive syndrome in cancer patients. Int J Clin Oncol. 28(4):603\u2013609","journal-title":"Int J Clin Oncol."},{"issue":"8","key":"6999_CR110","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10147-022-02194-w","volume":"27","author":"H Kawano","year":"2022","unstructured":"Kawano H, Hirahata M, Imanishi J (2022) Locomotive syndrome in cancer patients: a new role of orthopaedic surgeons as a part of comprehensive cancer care. Int J Clin Oncol. 27(8):1233\u20131237","journal-title":"Int J Clin Oncol."},{"issue":"6","key":"6999_CR111","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.jos.2021.07.018","volume":"27","author":"M Sato","year":"2022","unstructured":"Sato M, Furuya T, Shiga Y et al (2022) Assessment of locomotive syndrome in patients with visceral cancer, the comparison with non-cancer patients using propensity score matching. J Orthop Sci. 27(6):1328\u20131332","journal-title":"J Orthop Sci."},{"issue":"6","key":"6999_CR112","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jos.2025.04.002","volume":"30","author":"J Imanishi","year":"2025","unstructured":"Imanishi J, Morioka H, Hirahata M et al (2025) Institutional disparities in the treatment of bone metastases by orthopaedic surgeons at training facilities designated by the Japanese orthopaedic association-A nationwide survey. J Orthop Sci 30(6):1158\u20131164","journal-title":"J Orthop Sci"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-026-06999-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00264-026-06999-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-026-06999-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:07:21Z","timestamp":1790644041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00264-026-06999-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":112,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["6999"],"URL":"https:\/\/doi.org\/10.1007\/s00264-026-06999-6","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"value":"0341-2695","type":"print"},{"value":"1432-5195","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"2 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For the representative case demonstrated in Figure 2, written informed consent was obtained from the patient and her guardian for the publication of anonymized clinical data and accompanying images.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used generative AI technology (Gemini, Google) strictly for AI-assisted copy editing (improving readability, stylistic polish, and ensuring correct English grammar and formatting). All substantive content, conceptual ideas, literature selection, and generative editorial work were originated and critically verified by the authors, who take full human accountability for the final manuscript.","order":2,"name":"Ethics","label":"AI-Assisted copy editing","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}